|
Market Closed -
Nasdaq
04:00:00 08/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 146.85 USD | +1.82% |
|
-1.48% | +19.64% |
| 10-08 | Pharmaceutical Group Sues US Government Over Medicare Drug Pricing Rule | MT |
| 10-07 | Morgan Stanley Adjusts Price Target on Gilead Sciences to $163 From $165 | MT |
| Market Cap | 182B 163B 152B 138B 260B 17,614B 262B 1,824B 713B 8,958B 684B 669B 28,798B | P/E 2026 * |
-44.4x | P/E 2027 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 201B 179B 167B 152B 286B 19,432B 289B 2,012B 786B 9,883B 754B 738B 31,770B | EV / Sales 2026 * |
6.54x | EV / Sales 2027 * | 5.9x |
| Free-Float |
99.89% | Yield 2026 * |
2.24% | Yield 2027 * | 2.28% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| GILD | Delayed | |
CBOE
| GILD | Real-time | |
|
Xetra
| GIS | Delayed | |
|
Mexican S.E.
| GILD * | End-of-day quote | |
|
London S.E.
| 0QYQ | Delayed | |
|
Tradegate
| GIS | Real-time | |
|
Wiener Boerse
| GILD | End-of-day quote | |
|
Boerse Muenchen
| GIS | Real-time | |
|
CBOE
| Real-time | ||
|
Borsa Italiana
| 1GILD | End-of-day quote | |
|
Börse Stuttgart
| GIS | Delayed | |
|
Santiago S.E.
| GILD | End-of-day quote | |
|
Swiss Exchange
| GILD | Delayed | |
|
Lima
| GILDUS | End-of-day quote | |
|
Santiago S.E.
| GILDCL | End-of-day quote | |
|
Swiss Exchange
| GILD | Delayed | |
|
CBOE
| 0QYQ | Real-time | |
|
Deutsche Boerse AG
| GIS | Delayed |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +1.82% | ||
| 1 week | -1.48% | ||
| Current month | -1.48% | ||
| 1 month | -2.75% | ||
| 3 months | +7.69% | ||
| 6 months | +5.80% | ||
| Current year | +19.64% |
| 1 week | 142.6 |  | 148.6 |
| 1 month | 142.6 | | 154.2 |
| Current year | 116.88 | | 157.29 |
| 1 year | 114.02 | | 157.29 |
| 3 years | 62.07 | | 157.29 |
| 5 years | 57.16 | | 157.29 |
| 10 years | 56.56 | | 157.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 01/03/2019 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 01/11/2019 |
Keeley Wettan
CMP | Compliance Officer | - | 18/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 19/08/2016 |
| Director/Board Member | 73 | 01/01/2018 | |
Harish Manwani
BRD | Director/Board Member | 72 | 09/05/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/10/26 | Sell | Chief Executive Officer | -15,000 | 0.0012% | ||
| 22/9/26 | Exercice | Controller/Auditor | 5,214 | 0.0004% | ||
| 15/9/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.82% | -1.48% | +25.75% | +96.48% | 182B | |
| +2.70% | +2.73% | +40.91% | +110.31% | 1,060B | |
| +1.44% | -2.38% | +36.83% | +63.95% | 623B | |
| +1.75% | +3.73% | +16.55% | +83.05% | 480B | |
| +0.60% | -1.73% | +62.98% | +37.46% | 352B | |
| -1.40% | +1.52% | +21.63% | +41.24% | 345B | |
| -0.74% | +0.59% | +11.51% | +34.76% | 274B | |
| -0.62% | -2.01% | -5.85% | +10.84% | 249B | |
| +2.60% | -2.00% | +39.77% | +54.44% | 223B | |
| -0.65% | -0.69% | -33.07% | -60.71% | 168B | |
| Average | +0.25% | -0.41% | +21.70% | +47.18% | 395.61B | |
| Weighted average by Cap. | -0.01% | +0.05% | +28.71% | +64.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.71B 27.44B 25.6B 23.25B 43.8B 2,971B 44.12B 308B 120B 1,511B 115B 113B 4,857B | 32.72B 29.24B 27.28B 24.78B 46.67B 3,166B 47.01B 328B 128B 1,610B 123B 120B 5,175B |
| Net income | -4.27B -3.82B -3.56B -3.24B -6.1B -414B -6.14B -42.82B -16.73B -210B -16.05B -15.7B -676B | 10.28B 9.18B 8.57B 7.78B 14.65B 994B 14.76B 103B 40.21B 505B 38.57B 37.74B 1,625B |
| Net Debt | 18.79B 16.79B 15.66B 14.23B 26.8B 1,818B 27B 188B 73.54B 924B 70.55B 69.02B 2,972B | 11.14B 9.95B 9.28B 8.43B 15.88B 1,077B 16B 112B 43.58B 548B 41.81B 40.9B 1,761B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/10/26 | US$146.85 | +1.82% | 5,097,193 |
| 06/10/26 | US$144.23 | -0.28% | 3,723,588 |
| 05/10/26 | US$144.63 | -0.08% | 6,138,328 |
| 02/10/26 | US$144.74 | -1.87% | 5,044,221 |
| 01/10/26 | US$147.50 | -1.04% | 4,438,698 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
